Medivizor

Title of notification

Here comes the notification
X
 
icon
icon
colorectal cancer | Research | Treatment | 10 pages | source: The New England Journal of Medicine | Added Nov 02, 2019

Encorafenib, cetuximab and binimetinib combined treatment improves survival of patients with advanced colorectal cancer

This study investigated whether treatment with encorafenib (Braftovi), binimetinib (Mektovi), and cetuximab (Erbitux) combined would increase survival in advanced colorectal cancer (CRC). Researchers suggested that this combined therapy increases the survival of patients with metastatic (spread to other parts of the body) CRC.

icon
icon
colorectal cancer | Research | Treatment | 10 pages | source: Journal of clinical oncology | Added Oct 31, 2019

Oxaliplatin in the treatment of rectal cancer after surgery

This study investigated the role of oxaliplatin (Eloxatin) in treating patients with rectal cancer after surgery. Researchers suggested that this drug may be a good option in the treatment of rectal cancer.  

icon
icon
colorectal cancer | Research | Lifestyle | 10 pages | source: Journal of clinical oncology | Added Oct 20, 2019

Regular physical activity is associated with improved outcomes for advanced colorectal cancer

This study investigated the effectiveness of physical activity (PA) on the outcomes of patients with advanced colorectal cancer. Researchers suggested that regular PA is associated with better outcomes for these patients.

icon
icon
colorectal cancer | Research | Treatment | 10 pages | source: The Oncologist | Added Sep 27, 2019

Epidermal growth factor ointment improves the treatment of skin side effects in patients receiving treatment for colorectal cancer

This study investigated the effectiveness of epidermal growth factor (EGF) ointment to treat skin side effects in patients with colorectal cancer receiving epidermal growth factor receptor (EGFR) inhibitor treatment. Researchers suggested that EGF ointment improves the outcomes and quality of life of these patients.

icon
colorectal cancer | Clinical Trial | Added Sep 26, 2019

Looking for participants with advanced colorectal cancer to test a combination therapy

This phase 1/2 trial is examining the effectiveness of standard therapy alone or combined with new drugs as first line treatment for advanced colorectal cancer. The main outcome to be measured will be safety and tumor response to the treatment. 

icon
icon
colorectal cancer | Research | Treatment | 10 pages | source: The Lancet. Oncology | Added Sep 25, 2019

Treatment dose optimisation in patients with advanced colorectal cancer treated with regorafenib

This study investigated the effectiveness and safety of increasing doses of regorafenib (Stivarga) doses in patients with advanced colorectal cancer. Researchers suggested that this method with increasing doses should be used to assess the optimal dose for each patient.

icon
colorectal cancer | Clinical Trial | Added Sep 12, 2019

Looking for participants to test a vaccine for the treatment of advanced colorectal cancer

This phase 1b trial is examining the effectiveness and safety of a vaccine treatment, ATP128, in the treatment of advanced colorectal cancer. The main outcome to be measured is the tumor response to the treatment and treatment toxicity. This trial is being conducted in Arizona and California, US.

icon
colorectal cancer | Clinical Trial | Added Sep 10, 2019

Looking for patients with advanced colorectal cancer to test an experimental treatment

This phase 1/2 trial is examining the effectiveness of treatment with GB1275 alone or in combination with immunotherapy in patients with advanced solid tumors such as colorectal cancer. The main outcome to be measured will be dose toxicity and tumor response to the treatment. This study is being conducted in Tennessee and Texas, US.

icon
icon
colorectal cancer | Research | Treatment | 10 pages | source: Advances in therapy | Added Sep 08, 2019

The effects of maintenance vs intermittent therapy in the treatment of advanced colorectal cancer

This study investigated the effects of maintenance therapy (MT) compared to intermittent therapy (IT) for patients with metastatic (spread to other parts of the body) colorectal cancer. Researchers suggested that MT might improve the treatment of these patients.

icon
icon
colorectal cancer | Research | Treatment | 10 pages | source: British Journal of Surgery | Added Sep 04, 2019

Internal selective radiotherapy improves the outcomes of patients with colorectal cancer liver metastasis

This study investigated the effectiveness of selective internal radiation therapy (SIRT) in the treatment of colorectal cancer liver metastasis (CRC-LM). Researchers suggested that adding this therapy to the treatment improves the outcomes of the treatment.

View

Category

  • icon
  • icon
  • icon
  • icon
  • icon
  • icon
  • icon
  • icon
  • icon

Was this helpful?